Journal of Medicinal Chemistry · 1998 · 43 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryEnzymologyEnzyme InhibitionOrganic SynthesisPotency OptimizationProtein ChemistryEnzyme Inhibitor SynthesisMedicinal Chemistry ApplicationsPotency Assays
Potent and selective non-thiol-containing inhibitors of protein farnesyltransferase are described. FTI-276 (1) was transformed into pyridyl ether analogue 19. The potency of pyridyl ether 19 was improved by modification of the biphenyl core to that of an o-tolyl substituted biphenyl core to give 29. In addition to 0.4 nM in vitro potency, 29 displayed 350 nM potency in whole cells as the parent carboxylic acid. The o-tolyl biphenyl core dramatically and unexpectedly enhanced the potency of other compounds as exemplified by 46, 47, 48, and 49.
16
All ras proteins are polyisoprenylated but only some are palmitoylated
John F. Hancock, Anthony I. Magee, Julie E. Childs et al. · Cell · 1989 · 1.8K citations
p21ras is modified by a farnesyl isoprenoid.
Patrick J. Casey, Patricia A. Solski, Channing J. Der et al. · Proceedings of the National Academy of Sciences · 1989 · 855 citations · Full text
Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal Cells
Guy L. James, Joseph L. Goldstein, Michael S. Brown et al. · Science · 1993 · 629 citations
Medicine, Oncology, Pharmacology +15